Interstitial Cystitis Completed Phase 3 Trials for Omalizumab (DB00043)
Also known as: Cystitis, Interstitial / Cystitis, Chronic Interstitial / Interstitial cystitis (chronic) / Chronic interstitial cystitis NOS (disorder) / Chronic interstitial cystitis NOS / Chronic interstitial cystitis (disorder) [Ambiguous] / Chronic interstitial cystitis / Chronic interstitial cystitis (disorder) / Cystitis interstitial / Cystitis ulcerative / Ulcerative cystitis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028936 (Interstitial Cystitis) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01294878 | Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome | Treatment |